tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RAPP Stock Latest News

3 Best Stocks to Buy Now, 9/16/2025, According to Top Analysts
Market News3 Best Stocks to Buy Now, 9/16/2025, According to Top Analysts
12d ago
CHRD
NVDA
Rapport Therapeutics initiated with a Buy at Truist
PremiumThe Fly
Rapport Therapeutics initiated with a Buy at Truist
12d ago
RAPP
Rapport Therapeutics director buys $1.03M in common stock
PremiumThe Fly
Rapport Therapeutics director buys $1.03M in common stock
12d ago
RAPP
Rapport Therapeutics assigned Buy rating at Goldman Sachs
PremiumThe Fly
Rapport Therapeutics assigned Buy rating at Goldman Sachs
16d ago
RAPP
PremiumCompany Announcements
Rapport Therapeutics Announces Public Offering Agreement
17d ago
8K
RAPP
Rapport Therapeutics 9.62M share Secondary priced at $26.00
PremiumThe FlyRapport Therapeutics 9.62M share Secondary priced at $26.00
18d ago
RAPP
Closing Bell Movers: Nebius up over 40% on Microsoft deal
Premium
The Fly
Closing Bell Movers: Nebius up over 40% on Microsoft deal
19d ago
PL
APP
Premium
Company Announcements
Rapport Therapeutics Terminates Common Stock Prospectus
20d ago
8K
RAPP
Rapport Therapeutics announces $250M common stock offering
PremiumThe Fly
Rapport Therapeutics announces $250M common stock offering
20d ago
RAPP
Rapport Therapeutics price target raised to $56 from $35 at Stifel
PremiumThe Fly
Rapport Therapeutics price target raised to $56 from $35 at Stifel
20d ago
RAPP
EchoStar sells spectrum licenses to SpaceX, StubHub to launch IPO: Morning Buzz
PremiumThe Fly
EchoStar sells spectrum licenses to SpaceX, StubHub to launch IPO: Morning Buzz
20d ago
BA
PL
Morning Movers: EchoStar jumps following $17B spectrum deal with SpaceX
PremiumThe Fly
Morning Movers: EchoStar jumps following $17B spectrum deal with SpaceX
20d ago
EME
DNTH
Rapport Therapeutics price target raised to $34 from $31 at H.C. Wainwright
PremiumThe FlyRapport Therapeutics price target raised to $34 from $31 at H.C. Wainwright
20d ago
RAPP
Premium
Company Announcements
Rapport Therapeutics Reports Positive Phase 2a Trial Results
20d ago
8K
RAPP
Rapport Therapeutics says Phase 2a trial of RAP-219 met primary endpoint
Premium
The Fly
Rapport Therapeutics says Phase 2a trial of RAP-219 met primary endpoint
20d ago
RAPP
Rapport Therapeutics plans to hold end-of-Phase 2 meeting with FDA in Q4
PremiumThe Fly
Rapport Therapeutics plans to hold end-of-Phase 2 meeting with FDA in Q4
20d ago
RAPP
PremiumRatings
Positive Outlook for Rapport Therapeutics, Inc. Driven by RAP Technology and Strategic Focus on CNS Indications
1M ago
RAPP
PremiumRatings
Buy Rating for Rapport Therapeutics Driven by Upcoming Trial Milestone and Strong Pipeline Potential
1M ago
RAPP
PremiumCompany Announcements
Rapport Therapeutics Reports Q2 2025 Financials and Progress
2M ago
RAPP
PremiumCompany AnnouncementsRapport Therapeutics Reports Q2 Results and Updates
2M ago
8K
RAPP
Rapport Therapeutics reports Q2 EPS (75c), consensus (79c)
Premium
The Fly
Rapport Therapeutics reports Q2 EPS (75c), consensus (79c)
2M ago
RAPP
Rapport Therapeutics sees cash runway through end of 2026
Premium
The Fly
Rapport Therapeutics sees cash runway through end of 2026
2M ago
RAPP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >